Defunct Company
Total Trials
10
As Lead Sponsor
8
As Collaborator
2
Total Enrollment
10,914
NCT01168024
Contrast Media Reduction and Removal in Patients With Chronic Kidney Disease (CKD) (PRESERV)
Phase: N/A
Role: Lead Sponsor
Start: Dec 31, 2012
Completion: Nov 30, 2013
NCT02158442
Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients
Phase: Phase 2
Start: Oct 31, 2013
Completion: Mar 31, 2015
NCT01976299
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
Start: Dec 31, 2013
Completion: Sep 30, 2015
NCT02434055
Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS
Role: Collaborator
Start: Apr 30, 2015
Completion: Jun 30, 2015
NCT02436642
AVERT Plus Post-Market Registry
Start: May 31, 2015
NCT02606734
DyeVert Pilot Trial
Start: Oct 31, 2015
Completion: Dec 31, 2015
NCT02752802
DyeVert System RCT
Start: Apr 30, 2016
Completion: May 31, 2016
NCT03118544
REduction of Contrast Via DyeVert Used in CTO Procedures
Start: Mar 26, 2017
Completion: Feb 2, 2018
NCT03715452
DyeVert™ Plus Contrast Reduction System Multicenter Observational Study
Start: Jul 1, 2017
Completion: Mar 30, 2018
NCT03825094
DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry
Start: May 7, 2019
Completion: Dec 31, 2023